Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Article

Correlation between Resistance of Pseudomonas aeruginosa to Benzalkonium Chloride and Expression of efflux pump genes

Mohamed El-Sayed Osman, Hoda Hamed El-Hendawy, Said Mohamed Abd El-All, Ahmed Mohamed Hassan, Dina Ezzat Mahmoud.

Study of Cross-resistance to other antimicrobial agents and efflux pump (EP) resistance mechanism in Benzalkonium Chloride (BC) adapted Pseudomonas aeruginosa isolates.
Minimum inhibitory concentration of BC of 88 P. aeruginosa isolates that collected from clinical settings in Egypt and Cross-resistance of BC-adapted isolates to other antimicrobial agents were determined by agar dilution method. EP regulatory genes (i.e. MexR, NfxB, MexT, and MexZ) were detected by PCR in BC adapted isolates, and then EP activity of isolates which have these four genes was determined by cartwheel method followed by sequencing for the isolate which showed the highest EP activity. Finally; the expression of EP genes (MexA, MexC, MexE, and MexX) was determined in the same isolate by real-time polymerase chain reaction (RT-PCR) in presence and absence of the most potent efflux pump inhibitor (EPI).
Twenty isolates were BC-adapted with MIC 2048 mg/L, showed Cross-resistance to Cetrimide and Ciprofloxacin but not to other disinfectants used. The isolate no. 87 selected to be sequenced. Mutation founded in MexR (V126E) and MexZ (L138R) genes. By RT-PCR, Sertraline (the most potent EPI used) decreased the expression of the EP genes to three-folds. These results demonstrate that efflux-pump was the major mechanism of resistance to BC.

Key words: Pseudomonas aeruginosa, Benzalkonium Chloride (BC.), Cross-resistance, Efflux Pump, Efflux Pump inhibitors, Sertraline.

Full-text options

Full-text Article

American Journal of Diagnostic Imaging


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.